29 July 2024
For patients with patellofemoral pain syndrome, high-intensity laser therapy was associated with reduced pain and improved lower extremity function compared with ultrasound and nerve stimulation, according to published results.
To assess the efficacy of high-intensity laser therapy for patients with patellofemoral pain syndrome (PFPS), Ozge Ozlu and Esra Atilgan, from the Institute of Health Sciences at Istanbul Medipol University in Turkey, performed a single-blinded randomized controlled trial of 45 patients with PFPS.
Researchers randomly assigned patients to receive high-intensity laser therapy combined with exercise (n = 15), ultrasound transcutaneous electrical nerve stimulation (TENS) with exercise (n = 15) or ultrasound interferential current stimulation with exercise (n = 15) for 2 weeks.
Outcomes included VAS pain scores, knee flexion range of motion, quadriceps and hamstring muscle strength, Kujala scores, the lower extremity functional scale and the timed-up-and-go test.
Researchers found patients who received high-intensity laser therapy had greater reductions in pain, increases in knee flexion angle, improvements in Kujala scores and overall lower extremity function at 3 months compared with patients who received TENS and interferential current stimulation.
Researchers concluded high-intensity laser therapy may be effective for the treatment of PFPS, especially in combination with exercise such as vastus medialis strengthening, to reduce pain and improve function.
Print06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
87% of cancer patients give positive ratings for medical care quality
18 September 2024
The Russian market of fillers and biorevitalizers grew by 21% in the first half of 2024
18 September 2024
Pharma’s Patient Reach Problem: Billions Still Left Behind
17 September 2024
17 September 2024